| Name: | Bortezomib Impurity F |
| Catalogue No. | VL1200002 |
| CAS No. | N/A |
| Molecular Formula | C19H22N4O4 |
| Molecular Weight | 370.4 |
| Status | In-stock |
| IUPAC Name | (S)-N-(1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
| Description | Bortezomib Impurity F or (S)-N-(1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide is associate impurity of Bortezomib. is a potent first-in-class dipeptidyl boronic acid proteasome inhibitor. bortezomib is an anticancer agent.Bortezomib is employ to treat two forms of blood cancer in adults, multiple myeloma and mantle cell lymphoma (MCL). |
| References | “Sci-Hub | Severe Reversible Cardiac Failure after Bortezomib Treatment Combined with Chemotherapy in a Non-Small Cell Lung Cancer Patient: A Case Report | 10.1186/1471-2407-6-129.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1186/1471-2407-6-129. |
